Through computational predictions followed by experimental validations, we identified from this study that SNRPD1 over-expression is prognostic of high malignancies among breast cancer patients due to accelerated cell cycle, and proposed that targeting SNRPD1 could halt cell cycle progression at the G0/G1 phase for effective breast cancer management. This evidence concerns the gene SNRPD1 and breast carcinoma.